Trends in Melanoma Mortality in the Population Groups of South Africa.


Journal

Dermatology (Basel, Switzerland)
ISSN: 1421-9832
Titre abrégé: Dermatology
Pays: Switzerland
ID NLM: 9203244

Informations de publication

Date de publication:
2019
Historique:
received: 03 10 2018
accepted: 29 04 2019
pubmed: 4 7 2019
medline: 24 1 2020
entrez: 4 7 2019
Statut: ppublish

Résumé

The incidence of cutaneous melanoma (CM) is increasing in countries around the world. However, little is known about melanoma trends in African countries by population group. We studied CM mortality in South Africa from 1997 to 2014 to partly address this knowledge gap. Unit record mortality data for all South Africans who died from CM (n = 8,537) were obtained from Statistics South Africa. Join-point regression models were used to assess whether there was a statistically significant change in the direction and/or magnitude of the annual trends in CM mortality. A significant increasing trend of 11% per year was observed in age-adjusted mortality rates in men between 2000 and 2005 (p < 0.01), rising from 2 to 3 per 100,000. There was also a statistically significant increase of 180% per year among White South Africans from 1997 to 1999 (p < 0.05) and of 3% from 1999 to 2014 (p < 0.01). These results may be used to inform CM awareness campaigns and will motivate efforts to improve the collection and analysis of relevant statistics regarding the present burden of CM in South Africa.

Identifiants

pubmed: 31269484
pii: 000500663
doi: 10.1159/000500663
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-399

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Caradee Yael Wright (CY)

Environment and Health Research Unit, South African Medical Research Council, Pretoria, South Africa, cwright@mrc.ac.za.
Department of Geography, Geoinformatics and Meteorology, University of Pretoria, Pretoria, South Africa, cwright@mrc.ac.za.

Thandi Kapwata (T)

Environment and Health Research Unit, South African Medical Research Council, Johannesburg, South Africa.

Elvira Singh (E)

National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
School of Public Health, University of Witwatersrand, Johannesburg, South Africa.

Adele C Green (AC)

QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
Cancer Research UK, Manchester Institute and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Peter Baade (P)

Cancer Council Queensland, Brisbane, Queensland, Australia.

Patricia Kellett (P)

National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.

Mary Norval (M)

Biomedical Sciences, University of Edinburgh Medical School, Edinburgh, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH